The JAK2/STAT3 signaling pathway is preferentially activated in CD44+ breast cancer stem cell population over other cell populations, and hyaluronic acid synthase 1 (HAS1) is a STAT3 signaling-related molecule in basal-like breast cancer [21]. This evidence concerns the gene CD44 and breast carcinoma.